What the first 90 days of GLP-1 treatment actually involve.

Before day one: what has already happened

By the time your first shipment arrives, three things have occurred that shape your entire first 90 days. A licensed clinician has read your full intake, including your history, medications, and goals, and decided GLP-1 therapy is appropriate for you. They've chosen your starting dose, almost always the lowest one. And your prescription has been prepared for you by a state-licensed 503A compounding pharmacy.

That starting dose matters more than most people expect. GLP-1 medications are titrated, meaning the dose steps up gradually over months. Starting low isn't caution for its own sake: it gives your digestive system time to adapt, which is the difference between manageable early side effects and miserable ones.

Weeks 1–4: acclimation

Your first injection takes about thirty seconds, guided by step-by-step instructions in your member portal. Pick a day and keep it; the weekly rhythm is the whole routine.

Here's the honest part. The most common early side effects are nausea, constipation or diarrhea, and fatigue, and they cluster in these first weeks and after each dose increase. For most people they're mild and temporary. Eating smaller meals, going easy on rich or greasy food, and staying hydrated genuinely help.

What you probably won't feel yet is dramatic appetite change. Some people notice it in week one; for many it builds slowly. A quiet first month with mild side effects and little weight change is a normal first month.

“A quiet first month is a normal first month. The medication is working before you can feel it working.”

Dr. Alana Reyes, MD · Medical Director

Weeks 5–8: the working dose

If your first month goes well, your clinician steps your dose up. This is the range where many members describe the shift that's hard to explain until it happens: the constant background chatter about food, what to eat, when, whether you should, simply gets quieter. Meals feel satisfying sooner. Portions shrink without a fight.

Two things deserve attention here, and both are covered in guest columns in this journal. First, protein: with a smaller appetite it's easy to under-eat protein, and that's how muscle gets lost alongside fat. Protein first at every meal is the simplest protective habit. Second, strength: two or three short sessions a week tells your body to keep the muscle it has.

In large clinical trials of branded, FDA-approved GLP-1 medications taken alongside diet and exercise, participants lost a substantial share of body weight on average over roughly a year and a half. Your pace will be your own; the point of the trial data isn't a promised number, it's that consistent months compound.

Weeks 9–12: the review

Week 12 is a checkpoint your clinician has had on the calendar since your intake. By now there's real data: how you've responded, how you've tolerated each dose, what the trend looks like. The decision is rarely dramatic. Hold the dose, step it up, or slow down; occasionally, order labs to check the fuller picture.

This is also where plateaus first appear, and where they're most misunderstood. A stall at week 12 usually isn't failure; it's often the signal that your current dose has done its work and the titration schedule is doing exactly what it was designed to do. That decision belongs to the clinician who knows your chart, never to an auto-renewal system.

What the scale won't tell you

Somewhere in the first 90 days, most members notice changes the scale doesn't capture: clothes fitting differently before the number moves much, steadier energy through the afternoon, walking past the pantry without negotiating with it, better sleep. Clinicians call these non-scale victories. We'd just call them the point.

Track one or two of them deliberately. On the weeks the scale is stubborn, and there will be some, they're the more truthful measure of whether this is working.

When to message your clinician

The member portal exists so you never have to guess alone. Message your care team for the small things: storage, travel, a missed dose, "is this normal." Clinical questions are usually answered the same business day.

And know the short list that shouldn't wait: severe abdominal pain that doesn't pass, signs of an allergic reaction like swelling or trouble breathing, gallbladder symptoms such as pain with fever or yellowing skin, or signs of low blood sugar if you also take insulin or sulfonylureas. Those warrant immediate care first, and a message to your clinician after.

The bottom line

The first 90 days are a designed arc, not a leap of faith: a deliberately low start, a gradual climb, an honest checkpoint. The medication does its part on a schedule. Yours is simpler than it sounds: take the weekly dose, eat protein first, move a little, and tell your clinician the truth about how it's going.

Ninety days from now, you and your clinician will know something real about how your body responds. That knowledge, not any single week's number, is what the first quarter is for.

This article is for general information and education. It is not medical advice and is not a substitute for care from a licensed clinician who knows your history. Trial results cited describe branded, FDA-approved medications, not compounded preparations, which are not FDA-approved or evaluated; individual results vary and are never guaranteed. Review the important safety information on each treatment page.